EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Successful Treatment of Necrobiosis Lipoidica With Abrocitinib: A Case Report

Yuping Zhang, Yirong Li, Fengjiao Meng, Chen Li

Case Reports in Dermatology · 2025-04-26 · 1-9

DOI: 10.1159/000546134 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Necrobiosis lipoidica (NL) is a rare granulomatous disease with no standardized treatment guidelines. Case Presentation: We present a case of a patient who experienced ulcerative NL of the left leg for five years, during which traditional treatments proved ineffective. The patient was administered oral abrocitinib at a dosage of 100 mg per day. After two weeks of treatment, the patient's skin lesions ceased exuding and began to show improvement. By the ten-week mark, the patient's symptoms had significantly improved, with the ulcer healing and no new lesions appearing. No adverse events were reported during the four-month follow-up period. Conclusion: Abrocitinib may represent a rapid and safe treatment option for patients with refractory localized NL.Further studies are warranted to confirm these findings and evaluate long-term efficacy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →